Skip to main content
Back to Novo Holdings

Novo Holdings's Genetics Portfolio

Browse 5 Genetics companies funded by Novo Holdings. See funding amounts, founder contacts, and investment details.

Genetics Companies
5
Total Funding in Genetics
$197.5M

Genetics Portfolio Companies (5)

Export
BiotechnologyGeneticsHealth CareMedicalTherapeutics

Centauri Therapeutics is a UK-based biotechnology company focused on the discovery and development of life threatening diseases.

Alderley Park, United Kingdom
February 2026
$8.1M
Series A

Founder Contacts

19,000+ verified contacts

GeneticsHealth CareMedical

Sidera Bio harness human genetics, that helps in transformative medicines for patients.

Copenhagen, Denmark
December 2025
$109.0M
Series A

Founder Contacts

19,000+ verified contacts

BioinformaticsBiotechnologyGeneticsHealth CareOncology

Mission Bio develops only single-cell multi-omics platform integrating genotype and phenotype for cancer research and biomarker development.

San Francisco, United States
August 2025
Series Unknown

Founder Contacts

19,000+ verified contacts

BiotechnologyGeneticsHealth CareHealth DiagnosticsMedical

MedGenome develops a genomics-based diagnostics and research solution for healthcare providers to understand the genetic basis of diseases.

Bangalore, India
July 2025
$47.5M
Series E

Founder Contacts

19,000+ verified contacts

BiotechnologyGeneticsLife ScienceNeuroscience

Horama develops gene therapies for rare inherited ocular and CNS (central nervous system) diseases.

Paris, France
January 2025
$32.9M
Series A

Founder Contacts

19,000+ verified contacts

Explore Novo Holdings's Full Portfolio

View all companies funded by Novo Holdings across every industry and funding stage.

View Full Novo Holdings Portfolio